Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Triazoles/ administration & dosage"'
Autor:
Anne-Grete Märtson, Martijn Bakker, Jan-Willem C. Alffenaar, Tjip S. van der Werf, Anette Veringa, Edwin R. van den Heuvel, Lambert F.R. Span, Daan J Touw
Publikováno v:
International Journal of Antimicrobial Agents, 53(3), 325-329. Elsevier
International journal of antimicrobial agents, 53(3), 325-329. Elsevier Bedrijfsinformatie b.v.
International journal of antimicrobial agents, 53(3), 325-329. Elsevier Bedrijfsinformatie b.v.
BACKGROUND: During inflammation several cytochrome P450 enzymes are down-regulated. Recently it was shown that voriconazole metabolism is reduced during inflammation. Posaconazole, another triazole with broad-spectrum antifungal activity, is only to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55849d4750b6102e4a2f9a9a4e8a8ed3
https://research.tue.nl/nl/publications/2c2081c7-9ba7-4515-90b1-4b9b88ddc030
https://research.tue.nl/nl/publications/2c2081c7-9ba7-4515-90b1-4b9b88ddc030
Autor:
Jens Huober, Anita Giobbie-Hurder, J. Lüthi, G. Berthod, A. Schönenberger, O. Pagani, M. Simcock, Peter Brauchli, C. Genton, Khalil Zaman, S. Aebi, Beat Thürlimann
Publikováno v:
Annals of Oncology, vol. 23, no. 6, pp. 1474-1481
Zaman, K; Thürlimann, B; Huober, J; Schönenberger, A; Pagani, O; Lüthi, J; Simcock, M; Giobbie-Hurder, A; Berthod, G; Genton, C; Brauchli, P; Aebi, S (2012). Bone mineral density in breast cancer patients treated with adjuvant letrozole, tamoxifen, or sequences of letrozole and tamoxifen in the BIG 1-98 study (SAKK 21/07). Annals of oncology, 23(6), pp. 1474-1481. Oxford University Press 10.1093/annonc/mdr448
Zaman, K; Thürlimann, B; Huober, J; Schönenberger, A; Pagani, O; Lüthi, J; Simcock, M; Giobbie-Hurder, A; Berthod, G; Genton, C; Brauchli, P; Aebi, S (2012). Bone mineral density in breast cancer patients treated with adjuvant letrozole, tamoxifen, or sequences of letrozole and tamoxifen in the BIG 1-98 study (SAKK 21/07). Annals of oncology, 23(6), pp. 1474-1481. Oxford University Press 10.1093/annonc/mdr448
BACKGROUND The risk of osteoporosis and fracture influences the selection of adjuvant endocrine therapy. We analyzed bone mineral density (BMD) in Swiss patients of the Breast International Group (BIG) 1-98 trial [treatment arms: A, tamoxifen (T) for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73822c30544d5b00ec3e10c9ff561769
http://doc.rero.ch/record/300587/files/mdr448.pdf
http://doc.rero.ch/record/300587/files/mdr448.pdf
Autor:
IBIS-II investigators, Lamote, Jan
BACKGROUND: Third-generation aromatase inhibitors are more effective than tamoxifen for preventing recurrence in postmenopausal women with hormone-receptor-positive invasive breast cancer. However, it is not known whether anastrozole is more effectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3848::1c81b5a885c3b5142778be813427ed82
https://hdl.handle.net/20.500.14017/da4a7b30-dca7-4a4b-b669-bd7f56be5be8
https://hdl.handle.net/20.500.14017/da4a7b30-dca7-4a4b-b669-bd7f56be5be8
Publikováno v:
European Journal of Clinical Microbiology & Infectious Diseases
European journal of clinical microbiology & infectious diseases, 31 (6
European journal of clinical microbiology and infectious diseases
European journal of clinical microbiology & infectious diseases, 31 (6
European journal of clinical microbiology and infectious diseases
The purpose of this study was to evaluate efficacy and safety of voriconazole in patients with acute invasive aspergillosis (IA) in a real-life, clinical setting. This was a multicenter observational study in adult patients treated with voriconazole
Autor:
Saskia Bolay, Thierry Calandra, Oscar Marchetti, Andres Pascual, Thierry Buclin, Jacques Bille
Publikováno v:
Clinical Infectious Diseases, vol. 46, no. 2, pp. 201-211
BACKGROUND: Voriconazole is the therapy of choice for aspergillosis and a new treatment option for candidiasis. Liver disease, age, genetic polymorphism of the cytochrome CYP2C19, and comedications influence voriconazole metabolism. Large variations
Autor:
Vicky S Sabine, José Baselga, Stefan Michiels, J. Michael Dixon, Christos Sotiriou, Tarek Sahmoud, John M. S. Bartlett, Andrew H. Sims, Sherene Loi, Martine Piccart, Sandeep Singhal
Publikováno v:
PLoS ONE
Loi, S, Michiels, S, Baselga, J, Bartlett, J M S, Singhal, S K, Sabine, V S, Sims, A H, Sahmoud, T, Dixon, M, Piccart, M J & Sotiriou, C 2013, ' PIK3CA Genotype and a PIK3CA Mutation-Related Gene Signature and Response to Everolimus and Letrozole in Estrogen Receptor Positive Breast Cancer ', PLoS ONE, vol. 8, no. 1, e53292, pp.-. https://doi.org/10.1371/journal.pone.0053292
PloS one, 8 (1
PLoS ONE, Vol 8, Iss 1, p e53292 (2013)
Loi, S, Michiels, S, Baselga, J, Bartlett, J M S, Singhal, S K, Sabine, V S, Sims, A H, Sahmoud, T, Dixon, M, Piccart, M J & Sotiriou, C 2013, ' PIK3CA Genotype and a PIK3CA Mutation-Related Gene Signature and Response to Everolimus and Letrozole in Estrogen Receptor Positive Breast Cancer ', PLoS ONE, vol. 8, no. 1, e53292, pp.-. https://doi.org/10.1371/journal.pone.0053292
PloS one, 8 (1
PLoS ONE, Vol 8, Iss 1, p e53292 (2013)
The phosphatidylinositol 3' kinase (PI3K) pathway is commonly activated in breast cancer and aberrations such as PI3K mutations are common. Recent exciting clinical trial results in advanced estrogen receptor-positive (ER) breast cancer support mTOR
Publikováno v:
Infection, Vol. 31, No 4 (2003) pp. 241-243
BACKGROUND: The incidence of fungal infections, including those due to Aspergillosis species has continued to increase in recent years. Invasive aspergillosis remains an important cause of morbidity and mortality, despite therapeutics interventions.
Publikováno v:
Journal of Pediatric Hematology / Oncology, Vol. 32, No 2 (2010) pp. 85-87
Zygomycosis is an emerging, opportunistic fungal infection particularly affecting immunocomprised patients. We report the case of a 10-year-old girl who developed pulmonary zygomycosis because of Cunninghamella bertholletiae 1 year after undergoing b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b21738ae196889823ed5baf9428f5085
https://archive-ouverte.unige.ch/unige:20953
https://archive-ouverte.unige.ch/unige:20953
BACKGROUND: Sitagliptin is a novel agent for the treatment of type 2 diabetes either as monotherapy or in combination with metformin or a thiazolidinedione. OBJECTIVE: To review the efficacy and safety of sitagliptin in clinical trials and comment on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10561::c56836a09636497159dee90b007af07a
http://olympias.lib.uoi.gr/jspui/handle/123456789/18257
http://olympias.lib.uoi.gr/jspui/handle/123456789/18257
Autor:
Bresciani, E., Tamiazzo, L., Torsello, A., Bulgarelli, I., Rapetti, D., Caporali, S., Perrissoud, D., Moulin, A., Fehrentz, J. A., Jean Martinez, Locatelli, V.
Publikováno v:
Scopus-Elsevier
Eating and Weight Disorders-Studies on Anorexia, Bulimia and Obesity
Eating and Weight Disorders-Studies on Anorexia, Bulimia and Obesity, Springer Verlag, 2008, 13 (3), pp.e67-74
Eating and Weight Disorders-Studies on Anorexia, Bulimia and Obesity
Eating and Weight Disorders-Studies on Anorexia, Bulimia and Obesity, Springer Verlag, 2008, 13 (3), pp.e67-74
Journal Article Research Support, Non-U.S. Gov't Italy Ewd; Energy homeostasis is controlled by a complex regulatory system of molecules that affect food intake and that are critical for maintaining a stable body weight during life. Ghrelin is a pept
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::1807d5a58b4def906b8dbcfdb75848dd
https://hal.archives-ouvertes.fr/hal-00485776
https://hal.archives-ouvertes.fr/hal-00485776